Laurus Labs Limited has informed the Exchange regarding a press release dated November 19, 2021, titled "Laurus Labs acquires substantial minority stake in a CAR-Tcell therapy company - ImmunoACT.".
Laurus Labs Limited has informed the Exchange regarding a press release dated November 19, 2021, titled "Laurus Labs acquires substantial minority stake in a CAR-Tcell therapy company - ImmunoACT.".